We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics


Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App

Thermo Fisher Completes Acquisition of Data Intelligence Company CorEvitas

By LabMedica International staff writers
Posted on 16 Aug 2023
Print article
Image: CorEvitas will become part of Thermo Fisher’s Laboratory Products and Biopharma Services segment (Photo courtesy of Thermo Fisher)
Image: CorEvitas will become part of Thermo Fisher’s Laboratory Products and Biopharma Services segment (Photo courtesy of Thermo Fisher)

Thermo Fisher Scientific Inc. (Waltham, MA; USA) has completed the acquisition of CorEvitas, LLC (Waltham, MA; USA), a provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, for USD 912.5 million in cash. The announcement of this acquisition was initially made on July 6, 2023. Following the completion of the acquisition, CorEvitas will be incorporated into Thermo Fisher's Laboratory Products and Biopharma Services division.

Real-world evidence involves gathering and analyzing data on patient healthcare utilization and outcomes collected from regular clinical practice. This area has been experiencing rapid growth. Both pharmaceutical and biotech companies, along with regulatory authorities, are showing increased interest in monitoring the safety of approved treatments. They are also focusing on evaluating the effectiveness and value of these treatments after their approval.

CorEvitas offers regulatory-grade, real-world evidence solutions to pharmaceutical and biotech companies with objective data and clinical insights aimed at enhancing patient care and clinical outcomes. CorEvitas manages a total of 12 registries, including nine autoimmune and inflammatory syndicated registries. The company has created a multi-therapeutic data intelligence platform that can build and scale several clinical registries in specific therapeutic areas. This platform collects structured clinical data from over 400 research sites and tracks more than 100,000 patients over time.

“We are very excited to welcome our new CorEvitas colleagues to Thermo Fisher,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “CorEvitas expands our clinical research business with highly complementary real-world evidence solutions, which is an increasingly important area and will help to enhance decision-making as well as the time and cost of drug development. We are excited by the opportunity to further accelerate innovation and advance productivity for our pharma and biotech customers in their work to deliver new medicines and therapeutics to benefit patients.”

Related Links:
Thermo Fisher Scientific Inc. 

Platinum Supplier
Automatic Nucleic Acid Workstation
Gold Supplier
hCG Whole Blood Pregnancy Test
Concentrated Anionic Detergent
Hepatitis B Virus Test

Print article


Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Molecular Diagnostics

view channel
Image: A CRISPR technology-based diagnostic test detects MPXV in clinical samples with acute precision (Photo courtesy of 123RF)

Powerful Diagnostic Tool Accurately Detects Monkeypox Virus Faster Than Any Method

At present, testing for the monkeypox virus (MPXV) is done mainly in centralized labs, and it can take days to get results due to location and logistical issues. Now, researchers have leveraged cutting-edge... Read more


view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more


view channel
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers... Read more


view channel
Image: The rapid diagnostic test could pinpoint the correct antibiotic for infection treatment in under an hour (Photo courtesy of Microplate Dx)

Point-of-Care Device to Reduce Antibiotic Susceptibility Testing Time from Days to Minutes

Antimicrobial resistance (AMR) is a significant global health issue, currently leading to over 1.27 million deaths worldwide each year. By 2050, AMR could be causing up to 10 million deaths annually, surpassing... Read more


view channel
Image: The Tasso+ device has received CE Mark certification (Photo courtesy of Tasso)

Groundbreaking Blood Lancing Device Obtains Microliter Capillary Whole Blood Samples Painlessly

A convenient, virtually pain-free blood lancet that collects whole liquid blood samples has received CE Mark designation, making the patient-centric, high-volume blood collection solution available in... Read more


view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.